Skip to main content
Year archive

Novartis India Limited. — 2022 filings

All 92 regulatory filings released by Novartis India Limited. (NOVARTIND) in 2022, sourced directly from the official regulator.

92 Filings
2022 Period
2022 filings (92)
Filing Released Lang
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-12-27 English
Closure of Trading Window with effect from Wednesday, December 28, 2022 to Friday, February 10, 2023 (both days inclusive)
Regulatory Filings
2022-12-27 English
NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2023 ,inter alia, to consider and approve the Unaudited Financial Results ....
Regulatory Filings
2022-12-27 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-12-24 English
Postal Ballot Voting Results and Scrutinizer Report
Regulatory Filings
2022-12-24 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-12-22 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-12-19 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-12-15 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-12-14 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-12-13 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-12-12 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-12-06 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-12-01 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-11-25 English
Intimation of Newspaper Advertisement by Novartis India Limited - Completion of e-mailing of Notice of Postal Ballot to the Members of the Company
Regulatory Filings
2022-11-24 English
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Notice of Postal Ballot
Proxy Solicitation & Information Statement
2022-11-23 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-11-21 English
Intimation of Newspaper Advertisement by Novartis India Limited - Information regarding Postal Ballot/ E-voting
Regulatory Filings
2022-11-16 English
Intimation of Newspaper Advertisement regarding the Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2022
Regulatory Filings
2022-11-10 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-11-09 English
Appointment of Ms. Shilpa Joshi (DIN: 09775615) as Additional Director (designated as ''Whole-Time Director and Chief Financial Officer'') of the Company
Regulatory Filings
2022-11-09 English
Resignation of Ms. Monaz Noble (DIN: 03086192) as Director
Regulatory Filings
2022-11-09 English
Outcome of the Meeting of the Board of Directors of Novartis India Limited (''the Company'') held today i.e. Wednesday, November 09, 2022
Regulatory Filings
2022-11-09 English
Outcome of the Meeting of the Board of Directors of Novartis India Limited (''the Company'') held today i.e. Wednesday, November 09, 2022
Regulatory Filings
2022-11-09 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-10-21 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-10-17 English
Certificate in terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2022
Regulatory Filings
2022-10-11 English
NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 ,inter alia, to consider and approve Update on board meeting to ....
Regulatory Filings
2022-09-30 English
Intimation of meeting of the Board of Directors of Novartis India Limited and Closure of Trading Window
Regulatory Filings
2022-09-30 English
NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 ,inter alia, to consider and approve the Unaudited Financial Results ....
Regulatory Filings
2022-09-30 English
Intimation of meeting of the Board of Directors of Novartis India Limited and Closure of Trading Window
Regulatory Filings
2022-09-30 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-09-30 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-09-26 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-09-23 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-09-22 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-09-19 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-09-16 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-09-08 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-09-07 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-08-23 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-08-17 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-08-12 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-08-08 English
Proceedings of the 74th Annual General Meeting of Novartis India Limited ('the Company') held on Friday, July 29, 2022
Regulatory Filings
2022-07-29 English
Voting Results of the 74th Annual General Meeting of Novartis India Limited held on July 29, 2022 and Scrutinizers' Report
Regulatory Filings
2022-07-29 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-07-29 English
Intimation of Newspaper Advertisement by Novartis India Limited regarding the Unaudited Financial Results of the Company for the first quarter ended June 30, 2022
Regulatory Filings
2022-07-28 English
Outcome of the Meeting of the Board of Directors of Novartis India Limited held today i.e. Wednesday, July 27, 2022
Regulatory Filings
2022-07-27 English
Outcome of the Meeting of the Board of Directors of Novartis India Limited held today i.e. Wednesday, July 27, 2022
Regulatory Filings
2022-07-27 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-07-25 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-07-19 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-07-18 English
Certificate in terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2022
Regulatory Filings
2022-07-12 English
Newspaper Publication - Completion of sending of Notice of 74th Annual General Meeting along with Annual Report for the financial year 2021-22 to the Members
Report Publication Announcement
2022-07-01 English
NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2022 ,inter alia, to consider and approve the Unaudited Financial Results ....
Regulatory Filings
2022-06-30 English
Closure of Trading Window
Regulatory Filings
2022-06-30 English
Communication to Members of the Company - Intimation on tax deduction on Dividend
Regulatory Filings
2022-06-30 English
Notice convening the 74th Annual General Meeting of Novartis India Limited forming part of Annual Report for the financial year 2021-22
Regulatory Filings
2022-06-30 English
Annual Report for the financial year 2021-22 and Notice convening the 74th Annual General Meeting of Novartis India Limited
Regulatory Filings
2022-06-30 English
Notice to Members- Disclosure under Regulations 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-06-24 English
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-06-10 English
Transfer of Shares to Investor Education and Protection Fund (IEPF) pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure ....
Regulatory Filings
2022-06-08 English
Disclosure of Related Party Transactions for the half year ended March 31, 2022 under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI ....
Regulatory Filings
2022-06-02 English
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2022
Regulatory Filings
2022-05-24 English
Intimation of Newspaper Advertisement by Novartis India Limited ('the Company') regarding the Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2022.
Regulatory Filings
2022-05-20 English
The Board has recommended the appointment of M/s. B S R & Co. LLP, Chartered Accountants (ICAI FRN: 101248W/W-100022) as Statutory Auditors of the Company for a term of 5 (five) years to ....
Regulatory Filings
2022-05-19 English
The Register of Members and Share Transfer books shall be closed from Friday, July 22, 2022 to Friday, July 29, 2022, both days inclusive, for determining the eligibility of shareholders ....
Regulatory Filings
2022-05-19 English
The Board has recommended final dividend of Rs. 10 per equity share (of the face value of Rs. 5 each) for the financial year ended March 31, 2022, subject to the approval of the shareholders ....
Regulatory Filings
2022-05-19 English
Outcome of the Meeting of the Board of Directors of Novartis India Limited ('the Company') held on May 19, 2022
Regulatory Filings
2022-05-19 English
Outcome of the Meeting of the Board of Directors of Novartis India Limited ('the Company') held on May 19, 2022
Regulatory Filings
2022-05-19 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2022-04-30 English
Certificate under Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended March 31, 2022. This is for your information ....
Regulatory Filings
2022-04-28 English
Authorizing Key Managerial Personnel for determining Materiality of an event or information and for the purpose of making disclosures under Regulation 30(5) of SEBI (Listing Obligations ....
Regulatory Filings
2022-04-27 English
Appointment of Company Secretary and Compliance Officer of the Company
Regulatory Filings
2022-04-27 English
Change in management - Appointment of Chief Financial Officer of the Company
Regulatory Filings
2022-04-27 English
Outcome of the Meeting of the Board of Directors of Novartis India Limited held on Wednesday, April 27, 2022 for : 1. Appointment of Chief Financial Officer 2. Appointment of Company ....
Regulatory Filings
2022-04-27 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that as per the information received from the Company's ....
Regulatory Filings
2022-04-22 English
Please note that in terms of the SEBI (LODR) Regulations, 2015, the Company has obtained a Compliance Certificate from Saraf & Associates, Company Secretaries, for the financial year ended ....
Regulatory Filings
2022-04-21 English
In reference to the above captioned subject, the certificate dated April 8, 2022, issued by the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited, in terms ....
Regulatory Filings
2022-04-21 English
Novartis India Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on May 19, 2022, to inter alia consider the Audited financial results ....
Regulatory Filings
2022-03-31 English
NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2022 ,inter alia, to consider and approve the Audited financial results ....
Regulatory Filings
2022-03-31 English
Dear Sir/ Madam, Please be informed that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, May 19, 2022, to inter alia consider the Audited financial ....
Regulatory Filings
2022-03-31 English
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that we are issuing a duplicate share certificate to the ....
Regulatory Filings
2022-03-17 English
Dear Sirs, Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that as per the information received from the ....
Regulatory Filings
2022-02-25 English
Dear Sirs, Please find enclosed herewith the copies of the newspaper Notices in 'Financial Express' and 'Navshakti' on February 12, 2022. This is for your information and record.
Earnings Release Q3 2022
2022-02-15 English
Dear Sirs, Please find enclosed herewith the following: 1. Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 2. Media ....
Regulatory Filings
2022-02-11 English
Dear Sirs, Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that as per the information received from ....
Regulatory Filings
2022-02-10 English
Dear Sir/ Madam, Kindly note that the Board of Directors of the Company has in its meeting held today i.e. on Thursday, February 10, 2022 ("said meeting"), inter alia considered ....
Regulatory Filings
2022-02-10 English
Dear Sir/ Madam, Kindly note that the Board of Directors of the Company has in its meeting held today i.e. on Thursday, February 10, 2022 ("said meeting"), inter alia considered ....
Regulatory Filings
2022-02-10 English
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that as per the information received from the Company's Registrar ....
Regulatory Filings
2022-01-28 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that we are issuing a duplicate share certificates to the ....
Regulatory Filings
2022-01-17 English
In reference to the captioned subject, the certificate dated January 5, 2022, issued by the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited, in terms ....
Regulatory Filings
2022-01-13 English